Patent 10508143 was granted and assigned to Aleta Biotherapeutics on December, 2019 by the United States Patent and Trademark Office.
Compositions, e.g., compositions comprising cellular therapeutics and/or protein therapeutics, and methods of using such compositions for treating cancer are described.